Australia Stock Exchange release from ARGENICA THERAPE : Successful Completion of Final GLP Genotoxicity Studies
23/02/2022 21:09
Australia Stock Exchange release from ARGENICA THERAPE AGN.AX : Successful Completion of Final GLP Genotoxicity Studies
Recent news on Argenica Therapeutics
See all newsBrief: Argenica Therapeutics Says IND Application Advanced With Successful Completion Of Assay
Brief: Argenica Therapeutics Says Dianne Angus To Step Down As Non-Executive Chair
Australia's Argenica Therapeutics jumps on meeting FDA condition
Brief: Argenica Therapeutics Seeks Trading Halt
Brief: Argenica Therapeutics Gets Non-Dilutive Funding Up To A Total Of A$1.5M